[Form 4] ARAMARK Insider Trading Activity

Karen Marie King, a director of Aramark (ARMK), reported a non‑derivative acquisition on 08/20/2025.

Rhea-AI Filing Summary

Karen Marie King, a director of Aramark (ARMK), reported a non‑derivative acquisition on 08/20/2025. The filing shows 29.912 shares were acquired at $0 as dividend equivalent rights credited on deferred stock units; these rights vest on the same schedule as the underlying awards. After the transaction, the reporting person beneficially owned 37,614.967 shares directly. The report was signed by an attorney‑in‑fact on 08/21/2025.

Insights

Financial Analyst

TL;DR: Routine grant of dividend equivalent rights increased a director's direct holdings marginally; immaterial to company valuation.

The Form 4 documents a typical issuance of dividend equivalent rights tied to deferred stock units, resulting in the acquisition of 29.912 shares at no cash cost and increasing direct beneficial ownership to 37,614.967 shares. Such accruals are common as part of executive/director compensation and reflect the company’s dividend distribution mechanism rather than an opportunistic market purchase. There is no cash transaction, no change in control, and no derivative instruments reported, indicating limited immediate market impact.

Corporate Governance Expert

TL;DR: Filing reflects routine compensation accounting for a director; governance implications are standard and procedural.

The disclosure clarifies that these are dividend equivalent rights associated with deferred stock units and that vesting follows the underlying awards' schedule. This is a standard governance practice to align directors with shareholder interests through equity compensation. The signature by an attorney‑in‑fact indicates proper procedural filing. There are no indications of unusual timing, related‑party transactions, or accelerated vesting disclosed in this Form 4.

Insider Trade Summary

Grant/Award: 29.912 shares

Grant/Award 1 txn

Insider King Karen Marie

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	29.912	$0.00	$0.00

Holdings After Transaction: Common Stock — 37,614.967 shares (Direct)

Footnotes (1)

1. F1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transaction did ARAMARK director Karen Marie King report on Form 4?

The filing reports an acquisition of 29.912 shares on 08/20/2025 as dividend equivalent rights credited on deferred stock units.

Did Karen Marie King pay for the shares reported on ARMK Form 4?

No. The reported price is $0, indicating the shares were credited as dividend equivalents rather than purchased with cash.

How many ARAMARK shares does the reporting person beneficially own after the transaction?

The Form 4 states the reporting person beneficially owned 37,614.967 shares following the transaction.

What is the nature of the securities acquired in the ARMK Form 4?

They are non‑derivative common stock credited as dividend equivalent rights tied to deferred stock units; vesting follows the underlying awards.

When was the Form 4 for ARMK signed and filed?

The signature on the Form 4 is dated 08/21/2025 and the transaction date is 08/20/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/21/2025 - 04:26 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

King Karen Marie

(Last) (First) (Middle)

C/O ARAMARK

2400 MARKET STREET

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/20/2025		A		29.912(1)	A	$0	37,614.967	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

Remarks:

	/s/ Ryan S. Spengler, as Attorney-in-fact	08/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.